| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.9M | -58.6% |
| R&D Expense | $111.4M | +14.3% |
| SG&A Expense | $29.0M | +11.7% |
| Operating Income | -$120.4M | -60.1% |
| Interest Expense | $1.2M | +3237.8% |
| Net Income | -$119.7M | -59.4% |
| EPS (Basic) | -$1.32 | -38.9% |
| EPS (Diluted) | -$1.32 | -38.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.5M | -40.5% |
| Short-term Investments | $116.4M | +7.4% |
| Current Assets | $182.9M | -17.1% |
| Total Assets | $240.8M | -13.4% |
| Current Liabilities | $34.8M | -12.9% |
| Long-term Debt | $19.3M | — |
| Total Liabilities | $70.0M | +12.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$115.9M | -128.8% |
| Capital Expenditures | $5.9M | +7.5% |
| Investing Cash Flow | -$13.0M | +89.1% |
| Financing Cash Flow | $83.1M | -23.6% |
| Free Cash Flow | -$121.8M | -117.0% |
| Stockholders' Equity |
| $170.8M |
| -21.0% |